A cancer drug candidate called CADD522 increased bone volume and preserved fragile trabecular bone in female mice. Their ovaries had been removed to model postmenopausal bone loss.

The Fraunhofer Institute for Structural Durability and System Reliability LBF and the German Federal Institute for Materials Research and Testing (BAM) have launched the MultiCycCon research project.

Viridian Metals Inc. (CSE: VRDN) (OTCQB: VIRMF) reports initial assay results from its 2026 drill program at the Kraken Main ...

Space debris removal 2026 reaches a governance turning point as Zero Debris Week opens in Seville with the inaugural launch ...

New positive preclinical studies show that sabizabulin can overcome drug resistance to daraxonrasib with potent anticancer efficacy ...

What the Standard Panel Actually Tests The routine blood panel most Indian adults receive once a year checks a short list: complete blood count, fasting glucose, lipid profile, liver enzymes, kidney ...

Discover the top 16 websites to buy GLP-1 weight loss medications online. Our expert-reviewed guide helps you find safe and ...

A new scientific review concludes that cannabis-derived phytocannabinoids may have beneficial effects on bone health, ...

Tottenham Hotspur enhances stadium operations with cutting-edge technology. Discover the benefits of their digital upgrade.

Cancer cachexia, also called cancer-associated cachexia, is a multifactorial syndrome defined by progressive skeletal-muscle loss, with or without loss of fat mass. Conventional n ...

Volta Metals discovers significant rare earth elements in new drilling at the Springer project in Ontario, but economic ...